|
Bibliografia
Dettmar PW, Hampson FC, Jain A, Choubey S, Little SL, Baxter T.
Administration of an alginate based gastric reflux suppressant on the bioavailability of omeprazole. Indian J Med Res. 2006 Apr;123(4):517-24.
Dettmar PW, Little SL, Baxter T.
The effect of omeprazole pre-treatment on rafts formed by reflux suppressant tablets containing alginate. J Int Med Res. 2005 May-Jun;33(3):301-8.
Giannini EG, Zentilin P, Dulbecco P, Iiritano E, Bilardi C, Savarino E, Mansi C, Savarino V.
A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms.
Dig Dis Sci. 2006 Nov;51(11):1904-9.
Zentilin P, Dulbecco P, Savarino E, Parodi A, Iiritano E, Bilardi C, Reglioni S, Vigneri S, Savarino V.
An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry.
Aliment Pharmacol Ther. 2005 Jan 1;21(1):29-34.
Mandel KG et al. Review article: alginate-raft formulations in the treatment of heartburn and acid reflux. Aliment Pharmacol Ther. 2000; 14 86):669-90.
Lindow SW., Regnell P., Sykes J., Little S. An open-label, multicentre study to assess the safety and efficacy of a novel reflux suppressant (Gaviscon Advance) in the treatment of heartburn during pregnancy. Int. J. Clin, Pract, 2003,57(3):175-9
Kellaway IW. An open, crossover investigation of the gastric distribution and residence of alginate rafts assessed by gamma scintigraphic monitoring in healthy, non-patient volunteers following administration of single doses of Liquid Gaviscon and Gaviscon Advance.
Report dell'ottobre 1995.
|
